» Authors » R Gelisgen

R Gelisgen

Explore the profile of R Gelisgen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 97
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dogan Z, Ergun D, Durmus S, Sahin H, Senturk G, Gelisgen R, et al.
Eur Rev Med Pharmacol Sci . 2023 May; 27(9):3979-3992. PMID: 37203822
Objective: Oxidative stress and hypoxia play an important role in the pathogenesis of various cardiovascular diseases. We aimed to evaluate the effectiveness of sacubitril/valsartan (S/V) and Empagliflozin (EMPA) on hypoxia-inducible...
2.
Dogan Z, Durmus S, Ergun D, Gelisgen R, Uzun H
Eur Rev Med Pharmacol Sci . 2023 Apr; 27(7):2953-2963. PMID: 37070896
Objective: The aim of this study was to evaluate the effectiveness of ranolazine on hypoxia-inducible factor-1α (HIF-1α) and oxidative stress in H9c2 cardiomyocyte cells. Materials And Methods: We have assessed...
3.
Soyman Z, Durmus S, Ates S, Simsek G, Sozer V, Kundaktepe B, et al.
Acta Endocrinol (Buchar) . 2022 Aug; 18(1):13-19. PMID: 35975247
Purpose: The aim of the study was to investigate whether the circulating miR-132, miR-146a, miR-222, and miR-320 levels are used in the differential diagnosis of women with polycystic ovary syndrome...
4.
Arkan A, Atukeren P, Ikitimur B, Simsek G, Koksal S, Gelisgen R, et al.
Clin Biochem . 2020 Oct; 87:19-25. PMID: 33031820
Objective: The relationship between the severity of atherosclerotic coronary artery disease (CAD) and circulating levels of salusin-α, salusin-β and heregulin-β1 has been investigated. In addition, the relationship with these peptides...
5.
Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, et al.
Lupus . 2017 Apr; 26(10):1089-1094. PMID: 28420068
Objectives Childhood-onset systemic lupus erythematosus (cSLE) is a multisystemic autoimmune disease characterized by inflammatory organ damage by means of vasculitis. Pentraxin-3 (PTX3) is expressed locally at the sites of inflammatory...
6.
Erman H, Gelisgen R, Cengiz M, Tabak O, Erdenen F, Uzun H
Eur Rev Med Pharmacol Sci . 2016 Apr; 20(6):1015-22. PMID: 27049251
Objective: The present study was proposed to examine the matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and vascular endothelial growth factor (VEGF) in patients with metabolic syndrome (MetS), and...
7.
Tuten A, Erman H, Korkmaz G, Oncul M, Gelisgen R, Sozer V, et al.
Arch Gynecol Obstet . 2014 Jun; 290(5):1007-13. PMID: 24916561
Background: The main purpose of this study was to determine the maternal and umbilical cord blood oxidized LDL (oxLDL) and soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in early-...
8.
Korkmaz G, Inal B, Ortakoylu G, Irmak H, Kara A, Gelisgen R, et al.
Clin Lab . 2014 May; 60(4):599-607. PMID: 24779293
Introduction: The source of many diseases, including tumors, lies in an increased generation of reactive oxygen species resulting in oxidative stress. We investigated the relationships between advanced oxidation protein products...
9.
Acay A, Erdenen F, Altunoglu E, Erman H, Muderrisoglu C, Korkmaz G, et al.
Clin Lab . 2014 Jan; 59(11-12):1331-7. PMID: 24409668
Background: Asthma and chronic obstructive lung disease (COPD) are characterised by airway inflammation. Paraoxonasel (PON1) and arylesterase (AE) enzymes have the ability to protect HDL from oxidation and may have...
10.
Oncul M, Tuten A, Erman H, Gelisgen R, Benian A, Uzun H
Minerva Med . 2013 Oct; 104(5):527-35. PMID: 24101110
Aim: The aim of this paper was to investigate maternal and cord blood apelin, resistin and visfatin concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Methods: This...